The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study

The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study

BackgroundIn Korea, the National Cancer Screening Program (NCSP) was implemented in 1999 and provides biennial endoscopy for adults aged ≥40 years. The NCSP has contributed to the early detection of gastric cancer and reduction of associated mortality in Korea. Helicobacter p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seowoo Bae, Joon Sung Kim, Moon Won Lee, Gwang Ha Kim, Young-Il Kim, Woon Tae Jung, Gwang Ho Baik, Beom Jin Kim, Joongyub Lee, Mina Suh, Jae Gyu Kim
Format:	Article
Language:	English
Published:	JMIR Publications 2025-07-01
Series:	JMIR Research Protocols
Online Access:	https://www.researchprotocols.org/2025/1/e72228
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017-03-01)

Can Helicobacter pylori Eradication Prevent the Development of Gastric Cancer?
by: Chang Seok Bang, et al.
Published: (2016-12-01)

Russell Body Gastritis Disappeared after Helicobacter pylori Eradication
by: Key Jo Lee, et al.
Published: (2017-06-01)

Social Network Analysis: Type of Information and Characteristics of Its Delivery Regarding Helicobacter pylori in Korea
by: Chang Seok Bang, et al.
Published: (2016-12-01)

Current Status of the Third-Line Helicobacter pylori Eradication
by: Jae Ho Choi, et al.
Published: (2018-01-01)

A Comparison of Accuracy between IMMULITE2000® and GENEDIA® for Helicobacter pylori Infection
by: Seon Hee Lim, et al.
Published: (2020-03-01)

HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”
by: Gyeongseon Shin, et al.
Published: (2025-04-01)

First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018-06-01)

Effect of Diabetes Mellitus on Helicobacter pylori Eradication Therapy
by: Sung Eun Kim
Published: (2017-06-01)

Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01)

Is It More Effective to Prescribe a Proton Pump Inhibitor Separately before a Meal for the Eradication of Helicobacter pylori?
by: Gyu Won Lee, et al.
Published: (2018-06-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017-12-01)

Helicobacter pylori and Metabolic Diseases
by: Sung Eun Kim
Published: (2020-03-01)

Efficient Depth Map Estimation Method Based on Gradient Weight Cost Aggregation Strategy for Distributed Video Sensor Networks
by: Gwang-Soo Hong, et al.
Published: (2014-01-01)

Detection of Clarithromycin Resistance in Helicobacter pylori Using the AllplexTM H. pylori & ClariR Assay and the Ezplex® HP-CLA Real-Time PCR Kit
by: Tae-Woo Kim, et al.
Published: (2025-03-01)

Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment
by: Hyo-Joon Yang, et al.
Published: (2025-05-01)

Experts’ Perceptions Regarding Testing for Helicobacter pylori Infection During Upper Gastrointestinal Endoscopy and Subsequent Eradication Therapy
by: Ilsoo Kim, et al.
Published: (2025-03-01)

Cost effectiveness of Alternative Helicobacter pylori Eradication Strategies in the Management of Duodenal Ulcer
by: Bernie O'Brien, et al.
Published: (1997-01-01)

Screening and Eradication of Helicobacter pylori for Gastric Cancer Prevention
by: Hyunchul Lim
Published: (2021-06-01)

Criteria for the National Health Insurance Service Medical Care Benefit of Helicobacter pylori Treatment
by: Young-Il Kim, et al.
Published: (2022-09-01)

Examining the effect of underlying individual preferences for present over future on lung cancer screening participation: a cross-sectional analysis of a Korean National Cancer Screening Survey
by: Kui Son Choi, et al.
Published: (2020-07-01)

Salvage Regimens after Failure of Previous Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Hyo-Joon Yang, et al.
Published: (2021-03-01)

Is Genotypic Resistance-guide Eradication Therapy Effective for Patients with Refractory Helicobacter pylori Infection?
by: Sung Eun Kim
Published: (2018-12-01)

Eradication of Helicobacter pylori Infection Using 7-day PCR-based Tailored Therapy
by: Youngwoo Kim, et al.
Published: (2023-06-01)

Helicobacter pylori-negative Peptic Ulcer
by: Ji Hyun Song, et al.
Published: (2017-09-01)

Cost-effectiveness analysis of MASLD screening using FIB-4 based two-step algorithm in the medical check-up
by: Mimi Kim, et al.
Published: (2025-06-01)

Helicobacter pylori Isolation and Antibiotic Susceptibility Testing Using Rapidly Frozen Biopsy Samples
by: Kee Don Choi, et al.
Published: (2024-12-01)

Helicobacter pylori Eradication Restores the Diversity of Gastric Microbiota
by: Yong Sung Kim
Published: (2017-12-01)

Comparison of Gastric Cancer Screening Strategies between Helicobacter pylori-infected, -eradicated, and -naive Individuals
by: Sun-Young Lee
Published: (2022-12-01)

Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes
by: Ji Min Choi, et al.
Published: (2021-12-01)

Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
by: Rifat Atun, et al.
Published: (2019-06-01)

Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01)

Helicobacter pylori Eradication Therapy-associated Diarrhea
by: Hoon Gil Jo, et al.
Published: (2021-09-01)

An Usual Cause of Intermittent Dysphagia
by: Moon Won Lee, et al.
Published: (2017-03-01)

Navigating the Treatment Landscape for Widespread Superficial Esophageal Squamous Cell Neoplasia
by: Moon Won Lee, et al.
Published: (2025-05-01)

Gastric Microbiota Associated with Gastric Precancerous Lesions in <i>Helicobacter pylori</i>-Negative Patients
by: Han-Na Kim, et al.
Published: (2025-01-01)

Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
by: Jun Yong Choi, et al.
Published: (2021-02-01)

Role of Helicobacter pylori Eradication Therapy in Patients with Functional Dyspepsia
by: Sung Eun Kim
Published: (2023-06-01)

Anti-Inflammatory Mechanism of Polyunsaturated Fatty Acids in Helicobacter pylori-Infected Gastric Epithelial Cells
by: Sun Eun Lee, et al.
Published: (2014-01-01)